Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Acute myeloid leukemia stem cells.

John E Dick1

  • 1Division of Cell and Molecular Biology, University Health Network, Suite 7-700, 620 University Ave., Toronto, Ontario, Canada M5G 2C1. jdick@uhnres.utoronto.ca

Annals of the New York Academy of Sciences
|June 17, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

FATP2-mediated lipid metabolism enhances chimeric antigen receptor T-cell therapy resistance in B-cell acute lymphoblastic leukemia.

Leukemia·2026
Same author

Ex vivo expansion of hematopoietic stem and progenitor cells from human mobilized peripheral blood for gene therapy applications.

Molecular therapy : the journal of the American Society of Gene Therapy·2026
Same author

Human haematopoietic stem cells remember inflammatory stress.

Nature·2026
Same author

ATP2B1 expression identifies human hematopoietic stem cells with superior repopulation and self-renewal.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Transposable elements shape stemness in normal and leukemic hematopoiesis.

Nature genetics·2026
Same author

JAK2V617F reprograms Hypoxia Inducible Factor-1 to induce a non-canonical hypoxia regulon in myeloproliferative neoplasms.

Leukemia·2026
Same journal

Multiomics Profiling During Autoimmune Demyelination Highlights a Complex Regulatory Role for Ataxin-1 in B Cells.

Annals of the New York Academy of Sciences·2026
Same journal

Global Trends in Light Pollution and Their Relationship With Socioeconomic Factors.

Annals of the New York Academy of Sciences·2026
Same journal

Wired for Corruption: Inter-Brain Synchrony Encodes Bribery-Related Value Information and Predicts Bribery Agreement.

Annals of the New York Academy of Sciences·2026
Same journal

LM-YOLO: A Lightweight Multi-Scale Enhanced Model for Forest Smoke Detection Using Unmanned Aerial Vehicles.

Annals of the New York Academy of Sciences·2026
Same journal

Polyrhythm Perception and Production: A Scoping Review.

Annals of the New York Academy of Sciences·2026
Same journal

DARTS-CNN-BiLSTM: Intelligent Fault Diagnosis for Computer Numerical Control Machine Tool Feed System.

Annals of the New York Academy of Sciences·2026
See all related articles

Cancer stem cells (CSCs) drive tumor growth. Research confirms leukemic stem cells (LSCs) initiate acute myeloid leukemia (AML), revealing a hierarchical structure crucial for targeted therapies.

Area of Science:

  • Oncology
  • Hematology
  • Stem Cell Biology

Background:

  • Identifying cancer stem cells (CSCs) that sustain tumor growth is a critical challenge in cancer research.
  • The concept of CSCs driving neoplasms has existed for decades, but definitive proof is recent.
  • Early evidence for CSCs originated from acute myeloid leukemia (AML) studies using stem cell assays.

Purpose of the Study:

  • To review the evidence for the existence and role of leukemic stem cells (LSCs) in AML.
  • To discuss the implications of LSC heterogeneity for understanding leukemogenesis and therapy.
  • To highlight recent clonal-tracking studies on LSC self-renewal potential.

Main Methods:

  • Utilizing quantitative stem cell assays for leukemic stem cells (LSCs).

Related Experiment Videos

  • Employing transplantation studies in NOD/SCID mice to assess AML initiation capacity.
  • Conducting clonal-tracking studies to analyze LSC self-renewal and heterogeneity.

    • Main Results:

    • Demonstrated that only rare LSCs can initiate AML growth post-transplantation, establishing AML hierarchy.
    • Identified distinct classes of LSCs within the LSC compartment based on self-renewal capacity.
    • Provided conclusive proof for the existence of CSCs, specifically LSCs in AML.

    Conclusions:

    • LSC heterogeneity influences the leukemogenic process.
    • Understanding LSC classes and self-renewal is vital for developing effective AML therapies.
    • Targeting and eradicating LSCs offers a promising strategy for AML treatment.